Kristie-Ann Dickson
8PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 28, 2025
Revealing genetic drivers of ovarian cancer and chemoresistance: insights from whole-genome CRISPR-knockout library screens.Tali S Skipper, Kristie-Ann Dickson, Christopher E Denes
|Sep 14, 2024
Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies-Therapeutic Vulnerabilities in Treatment-Resistant Subtypes.Yue Ma, Natisha R Field, Tao Xie
|Oct 14, 2022
Targeting Homologous Recombination Deficiency in Ovarian Cancer with PARP Inhibitors: Synthetic Lethal Strategies That Impact Overall Survival.Tao Xie, Kristie-Ann Dickson, Christine Yee
|Apr 23, 2022
The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells.Dongli Liu, Gunnar F Kaufmann, James B Breitmeyer
|Oct 22, 2021
An organotypic model of high-grade serous ovarian cancer to test the anti-metastatic potential of ROR2 targeted Polyion complex nanoparticles.Nidhi Joshi, Dongli Liu, Kristie-Ann Dickson
|Aug 27, 2021
PARP Inhibitors Display Differential Efficacy in Models of BRCA Mutant High-Grade Serous Ovarian Cancer.Kristie-Ann Dickson, Tao Xie, Christian Evenhuis
Pageof 2
Frequent Collaborators
7 joint publications
Deborah J Marsh
4 joint publications
Yue Ma
3 joint publications
Nikola A Bowden
2 joint publications
Tao Xie
2 joint publications
Dongli Liu
2 joint publications
Caroline E Ford
2 joint publications
Tali S Skipper
1 joint publications
Martina H Stenzel
1 joint publications
Natisha R Field
1 joint publications
Amani Alghalayini
